Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.

Tomalka, Jeffrey A; Suthar, Mehul S; Deeks, Steven G; Sekaly, Rafick Pierre

Tomalka, Jeffrey A; Suthar, Mehul S; Deeks, Steven G; Sekaly, Rafick Pierre.

Affiliation

Tomalka JA; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Suthar MS; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
Deeks SG; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
Sekaly RP; Department of Pediatrics, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA, USA.

Nat Immunol ; 23(3): 360-370, 2022 03.

Article in En | MEDLINE | ID: mdl-35210622

Subject(s)

Biological Variation, Population; COVID-19 Vaccines/immunology; COVID-19/epidemiology; COVID-19/prevention & control; Host-Pathogen Interactions/immunology; Immunity; SARS-CoV-2/immunology; Antibodies, Viral; COVID-19/virology; COVID-19 Vaccines/administration & dosage; Global Health; Host Microbial Interactions/immunology; Humans; Immunity, Humoral; Immunity, Innate; Immunogenicity, Vaccine; Immunologic Memory; Microbiota/immunology; Pandemics; Public Health Surveillance; Vaccination

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Host-Pathogen Interactions / Biological Variation, Population / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Immunity Type of study: Prognostic_studies Language: En Journal: Nat Immunol Year: 2022 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google